The Neural Masquerade of Cancer: Neuron–Tumor Crosstalk Drives Small-Cell Lung Cancer and Brain Metastasis

Over the past decade a remarkable paradigm shift has occurred in oncology.Once viewed as self-contained proliferative entities, tumors are now understood as active participants in the host multicellular system that continuously communicate with stromal, immune, and neural networks.Among these interactions, the dialogue between cancer and the nervous system has emerged as one of the most transformative discoveries in recent years.Electrical activity, neurotransmission, and synaptic communication, long thought to be the exclusive language of neurons, are now recognized as central regulators of tumor metabolism, and progression.The convergence of neuroscience and oncology has given rise to a new frontier, neuron-tumor crosstalk, which is defined by three core features (structural connectivity, functional signal transmission, and bidirectional regulation).The nervous system is not a passive bystander but a potent driver of malignancy.Two 2025 studies published in Nature now extend this concept to one of the most lethal neuroendocrine malignancies (small-cell lung cancer [SCLC]).Sakthivelu et al. demonstrated that SCLC cells form bona fide, functional synapses with neurons [1], while Savchuk et al. reported that neuronal activity governs SCLC initiation, progression, and brain metastasis [2].Together, these studies illuminated a new layer of malignant complexity, in which cancer not only responds to neural cues but joins the circuit, harnessing electrical communication to sustain growth.